Cellvizio

Cellvizio is a revolutionary technology that allows doctors to see cells inside the body live during endoscopic procedures. Unlike traditional methods, it provides instant, high-resolution real-time microscopic imaging, significantly improving diagnostic and treatment processes.

Developed by Mauna Kea Technologies, this technology is used safely in hundreds of clinics worldwide. Cellvizio enables doctors to examine the cellular structure of tissues instantly on-screen without the need for a biopsy. This facilitates the early diagnosis of diseases and allows for more effective guidance of treatments. The real-time microscopic imaging data obtained with Cellvizio supports doctors’ decision-making processes, helping to achieve better outcomes for patients.

What is Cellvizio?

Cellvizio is an innovative imaging technology that gives doctors the ability to see cells inside the body in real-time. This technology is called confocal laser endomicroscopy (CLE). Simply put, it allows for microscopic examination of tissues at the cellular level using a safe laser light. This enables doctors to observe the cellular signs of diseases live. The power of confocal laser endomicroscopy (CLE) lies in its ability to provide this information instantly. You can think of it as a super-powerful miniature camera attached to the end of a standard endoscope, showing the doctor a live video of the cells inside your body. Cellvizio is not a completely new or separate procedure; it works in conjunction with existing standard endoscopic devices. This integration eliminates the need for patients to undergo an additional procedure and makes standard examinations much more detailed, increasing the potential for early diagnosis.

What are the features of Cellvizio?

Cellvizio is equipped with advanced features that provide significant advantages to healthcare professionals in clinical practice:

• Intuitive Use: Its touch screen and one-handed probe connection offer quick setup and easy operation, increasing operational efficiency.
• Easy Integration: The Picture-in-Picture (PiP) feature allows for simultaneous work on the same screen as the endoscopy image. DICOM compatibility ensures that patient data can be easily transferred and archived into existing systems.
• Compact Design: The device’s compact structure allows it to be easily moved even in confined spaces like operating rooms and seamlessly integrates with existing equipment.
• Artificial Intelligence Support: AI-powered image analysis accelerates the detection of cellular-level abnormalities and increases diagnostic accuracy, strengthening doctors’ decision-making processes.

In which diseases can it be used?

Cellvizio provides critical cellular-level information to doctors, facilitating the diagnosis of diseases, especially in specialty areas such as gastroenterology, pulmonology, and urology. In the field of gastroenterology, it is used for monitoring esophageal conditions like Barrett’s esophagus, and for evaluating stomach and intestinal polyps and pancreatic cysts. This allows suspicious tissues to be examined instantly, speeding up the diagnostic process and preventing unnecessary biopsies. Pulmonology specialists use Cellvizio to examine suspicious nodules in the lungs and abnormal formations in the airways. This method confirms the diagnosis, offering significant contributions to clinical practice. In urology, the microscopic analysis of suspicious lesions in the bladder or ureter provides vital data for accurate disease staging and treatment planning.

Which method is used for Cellvizio?

Cellvizio operates using the confocal laser endomicroscopy (CLE) method. This advanced technique sends a harmless, low-power laser beam into the tissue. The system then captures the light that reflects off the cells, instantly creating dynamic, high-resolution microscopic images on a monitor. A key advantage of this innovative method is its exceptional safety profile; it is completely radiation-free, ensuring a risk-free diagnostic procedure for the patient.

How is it applied?

For the patient, the Cellvizio process is identical to standard endoscopic procedures. The application integrates seamlessly into the routine examination. First, the physician uses a standard endoscope to navigate and identify a suspicious area. Once located, Cellvizio’s miniature probe is guided through the endoscope’s working channel until it makes contact with the target tissue. The physician can then instantly view real-time, high-resolution cellular images on the screen, greatly enhancing the diagnostic precision of endoscopic procedures.

How long does the application/procedure take?

Cellvizio is designed to integrate seamlessly into existing endoscopic procedures. Consequently, using the technology adds only a few minutes to a standard endoscopy or bronchoscopy. It does not require additional preparation or extended procedure time for the patient, thus maintaining diagnostic efficiency and patient comfort. This quick integration provides valuable cellular-level insights without disrupting the clinical workflow.

Is the Cellvizio procedure painful?

The Cellvizio procedure itself does not cause additional pain. The process is carried out while the patient is already under anesthesia for the standard endoscopic procedure. Since the miniature probe is guided through the existing endoscope, patients do not experience any extra pain or discomfort. This integration allows for the collection of valuable cellular-level information without compromising the patient’s comfort.

Which patients is it applied to?

Cellvizio is applied to patients for whom an endoscopy, bronchoscopy, or cystoscopy has been planned by doctors for the diagnosis or monitoring of a specific condition. This technology is an added step to standard procedures and does not require a separate process for the patient. During the application, doctors can instantly examine suspicious areas at the cellular level, confirming the diagnosis and guiding the treatment process more accurately. This approach enhances the diagnostic power of standard examinations.

Who is not suitable for Cellvizio application?

Suitability for the Cellvizio application primarily depends on the patient’s eligibility for a standard endoscopic procedure. Therefore, conditions that pose a risk for general anesthesia or endoscopy, such as severe heart/lung diseases or bleeding disorders, also make Cellvizio unsuitable. The final decision on whether a patient is a suitable candidate for this technology is made by the specialist physician, who evaluates the patient’s overall health status and existing risks.

What are the advantages?

Cellvizio offers significant advantages that transform diagnostic and therapeutic approaches. Its unique capabilities provide critical insights during procedures:

• Instant Diagnosis: It provides doctors with real-time microscopic imaging of tissues at a cellular level. This speeds up the diagnostic process and reduces waiting times for patients.
• Precise Biopsy Targeting: Cellvizio helps pinpoint the exact area for a biopsy, significantly increasing diagnostic accuracy. By quickly ruling out non-suspicious areas, it can also prevent unnecessary biopsies in some cases.
• Faster Treatment Planning: The instant cellular-level information allows doctors to shape the treatment plan more quickly and effectively during the procedure itself, helping guide patients to the right therapy sooner.

Are there any side effects of using Cellvizio?

Cellvizio itself has no known specific side effects. Since it operates with a safe, low-power laser, it does not pose an additional risk to the patient. As this technology is applied during standard endoscopic procedures, any potential risks are the same as those associated with these procedures. Therefore, any risks related to the procedure stem from the general endoscopy application, not from Cellvizio itself, and patient safety is always the top priority.

What should be considered after the application?

Post-procedure care following a Cellvizio application is identical to that of a standard endoscopy, as the technology is integrated into the routine procedure. Therefore, it does not require any special recovery protocols. Patients must strictly follow their doctor’s specific instructions on diet, activity, and medication to ensure a safe and proper recovery.